Table 2 The relationship between TSR and pathological characteristics of PMP
Items | n (%) | TSR | P | |
|---|---|---|---|---|
< 10% | ≥ 10% | |||
Histopathological type | ||||
LG-PMP | 25 (50.0) | 23 | 2 | < 0.001 |
HG-PMP | 25 (50.0) | 8 | 17 | |
Vascular tumor emboli | ||||
Yes | 4 (8.0) | 1 | 3 | 0.293 |
No | 46 (92.0) | 30 | 16 | |
Nerve invasion | ||||
Yes | 3 (6.0) | 0 | 3 | 0.095 |
No | 47 (94.0) | 31 | 16 | |
Lymph node metastasis | ||||
Yes | 5 (10.0) | 2 | 3 | 0.560 |
No | 45 (90.0) | 29 | 16 | |
Ki67 label index | ||||
< 25% | 18 (36.0) | 17 | 1 | 0.001 |
25-50% | 18 (36.0) | 10 | 8 | |
≥ 50% | 14 (28.0) | 4 | 10 | |
p53 | ||||
Wild type | 19 (38.0) | 15 | 4 | 0.053 |
Mutant type | 31 (62.0) | 16 | 15 | |
MUC1 | ||||
+ | 26 (74.3) | 16 | 10 | 1.000 |
- | 9 (25.7) | 5 | 4 | |
MMR protein expression | ||||
Normal | 28 (93.3) | 15 | 13 | 0.464 |
Loss | 2 (6.7) | 0 | 2 | |
CDX2 | ||||
+ | 35 (83.3) | 21 | 14 | 0.676 |
- | 7 (16.7) | 3 | 4 | |
CK7 | ||||
+ | 25 (55.6) | 14 | 11 | 0.787 |
- | 20 (44.4) | 12 | 8 | |
CK20 | ||||
+ | 44 (95.7) | 26 | 18 | 1.000 |
- | 2(4.3) | 1 | 1 | |